American Healthcare (AHR) Earnings Analysis
American Healthcare (AHR) next reports earnings on 2026-08-06, consensus EPS 0.1372 USD. Last quarter (2026-05-07) it missed with EPS 0.13 USD vs 0.1609 USD est (-19.2%). It has beaten estimates in 0/7 recent quarters (0%). Trailing P/E 98.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AHR next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.1372 USD |
| Revenue estimate | 0.65B |
AHR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.13 USD | 0.1609 USD | -19.2% | Miss |
| 2026-02-26 | 0.06 USD | 0.1549 USD | -61.3% | Miss |
| 2025-11-06 | 0.33 USD | 0.42 USD | -21.4% | Miss |
| 2025-08-07 | 0.06 USD | 0.4 USD | -85% | Miss |
| 2025-05-08 | -0.04 USD | 0.37 USD | -110.8% | Miss |
| 2025-02-27 | -0.21 USD | 0.4 USD | -152.5% | Miss |
| 2024-08-05 | 0.01 USD | 0.29 USD | -96.6% | Miss |
Beat rate: 0/7 (0%) over reported quarters with consensus data.
AHR valuation and analyst view
| Trailing P/E | 98.01 |
|---|---|
| Trailing EPS | 0.53557 USD |
| Price / book | 3.07 |
| Dividend yield | 1.75% |
| Market cap | 11.83B |
| Analyst consensus | Buy (12 buy / 0 hold / 0 sell) |
| Avg price target | 61.6 USD |
Related research pages
Frequently asked questions
When is American Healthcare (AHR)'s next earnings date?
American Healthcare is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.1372 USD and revenue estimate of 0.65B.
Did AHR beat earnings last quarter?
In its 2026-05-07 report, AHR posted EPS of 0.13 USD versus a 0.1609 USD estimate — a miss of 19.2%.
What is AHR's earnings track record?
Over the last 7 reported quarters with consensus data, AHR beat estimates 0 times (0%).
What is AHR's current P/E ratio and EPS?
AHR trades at a trailing P/E of 98.01 on trailing EPS of 0.5355701473414478 USD.
What do analysts rate AHR?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 61.6 USD.